Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Key Inclusion Criteria:~* moderate to severe Crohn's Disease~* CDAI 250-450~* CRP \>7.5~* signed written informed consent~Key Exclusion Criteria:~* \> 100 cm of small bowel resected~* ileostomy, colostomy or rectal pouch~* diagnosis of ulcerative colitis or indeterminate colitis~* evidence of short bowel syndrome requiring enteral or parenteral supplementation or total parenteral nutrition~* hepatitis B, C or HIV infection~* history of infection requiring IV antibiotics~* serious or GI infection in the previous 12 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Blinded study arm
- 2 (Type: EXPERIMENTAL): Blinded study arm
- 3 (Type: EXPERIMENTAL): Blinded study arm
- 4 (Type: EXPERIMENTAL): Blinded study arm

Based on this trial design, predict the completion outcome and termination type (if applicable).